Quarterly report · Q1
7745.TEDINET S100OYU3
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.0bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥51.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | −¥219m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥847m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | −¥1m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥956m | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥6m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥957m | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥159m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥570m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥153m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥698m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥64.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥59.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥53.9bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥32.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥23.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.7bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-5.83 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.92 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.64 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥172.66 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.58 | 2021-04-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 47.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.9% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 97
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥1.6bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥18m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥102m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥116m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥917m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥175m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.5bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥132m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥124m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥231m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥230m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥10m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥131m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥15m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥652m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥7.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥272m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥10.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥792m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥4.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥4.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥294m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥875m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥822m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥52m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥81m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.8bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.8bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥3m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥45m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥606m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥117m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥166m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥8m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥212m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥212m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥4m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥130m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥3.9bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥3.3bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥587m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥184m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥3.1bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥535m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥407m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥6.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥5.4bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥14m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥8.3bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥4.9bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥3.4bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥720m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥407m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 450
| Item | Context | Value | Unit |
|---|---|---|---|
| Other cl | Prior1YearInstant | 4285000000 | JPY |
| Other cl | CurrentQuarterInstant | 4933000000 | JPY |
| Current liabilities | Prior1YearInstant | 26202000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 27811000000 | JPY |
| Bonds payable | Prior1YearInstant | 500000000 | JPY |
| Bonds payable | CurrentQuarterInstant | 500000000 | JPY |
| Long term loans payable | Prior1YearInstant | 3813000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 3333000000 | JPY |
| Provision for product warranties ncl | Prior1YearInstant | 49000000 | JPY |
| Provision for product warranties ncl | CurrentQuarterInstant | 87000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1034000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 1060000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | Prior1YearInstant | 83000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | CurrentQuarterInstant | 88000000 | JPY |
| Other ncl | Prior1YearInstant | 514000000 | JPY |
| Other ncl | CurrentQuarterInstant | 586000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 5995000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 5656000000 | JPY |
| Liabilities | Prior1YearInstant | 32198000000 | JPY |
| Liabilities | CurrentQuarterInstant | 33468000000 | JPY |
| Capital stock | Prior1YearInstant | 6388000000 | JPY |
| Capital stock | CurrentQuarterInstant | 6388000000 | JPY |
| Capital surplus | Prior1YearInstant | 6413000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 8318000000 | JPY |
| Retained earnings | Prior1YearInstant | 14367000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 13873000000 | JPY |
| Treasury stock | Prior1YearInstant | -1044000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -181000000 | JPY |
| Shareholders equity | Prior1YearInstant | 26125000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 28400000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 26000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 22000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -2278000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 2249000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 282000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 259000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -1969000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 2531000000 | JPY |
| Non controlling interests | Prior1YearInstant | 2885000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 131000000 | JPY |
| Net assets | Prior1YearInstant | 27041000000 | JPY |
| Net assets | CurrentQuarterInstant | 31062000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 59239000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 64530000000 | JPY |
| Net sales | Prior1YTDDuration | 11541000000 | JPY |
| Net sales | CurrentYTDDuration | 11981000000 | JPY |
| Cost of sales | Prior1YTDDuration | 6329000000 | JPY |
| Cost of sales | CurrentYTDDuration | 7604000000 | JPY |
| Gross profit | Prior1YTDDuration | 5211000000 | JPY |
| Gross profit | CurrentYTDDuration | 4376000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |